A Blueprint for Drug/Diagnostic Co-Development: Next-Generation Sequencing (NGS) in Oncology (September 2014)
A Risk-based Approach for In Vitro Companion Diagnostics Device FDA Approval Process Associated with Therapies that have Breakthrough Designation (September 2013)
Eliminating Breast Cancer Health Disparities: Communicating to At-Risk Populations (2012)
Developing Standards for Breakthrough Therapy Designation: Info Brief (2012)
Design of a Disease-Specific Master Protocol: Info Brief (2012)
Re-evaluating Criteria for Accelerated Approval: Info Brief (2012)
The New Role of Academia in Drug Discovery & Development (December 2010)
1800 M Street NW, Suite 1050 South,Washington, DC 20036Phone: (202) 944-6700
Friends of Cancer Research is a 501 (C)(3) non-profit organization.Our tax ID number is 52-1983273.
© Copyright 2020 Friends of Cancer Research. All rights reserved.